71
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of The Polish Acute Leukemia Group

, MD, , , , , , , , , , & show all
Pages 478-480 | Received 23 Jun 2008, Accepted 18 Dec 2008, Published online: 01 Jul 2009

References

  • US Food and Drug Administration. FDA Oncology Tools Product Label Details for methotrexate, Available at: http://www.accessdata.fda.gov/scripts/cder/onctools/labels.cfm?GN=methotrexate. Accessed August 2000
  • US Food and Drug Administration. FDA Oncology Tools Product Label Details for cytarabine, Available at: http://www.accessdata.fda.gov/scripts/cder/onctools/prescribe.cfm?GN=cytarabine. Accessed February 2002
  • EMEA. DepoCyte EPAR, Available at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/depocyte/126901en6.pdf
  • Glantz M J, LaFollette S, Jaeckle K A, Shapiro W, Swinnen L, Rozental J R, et al. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999; 17: 3110–3116
  • Jabbour E, O'Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, et al. Neurological complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high dose methotrexate and cytarabine to patients with acute lymphoblastic leukemia. Blood 2007; 109: 3214–3218
  • Sancho J M, Ribera J M, Romero M J, Martín-Reina V, Giraldo P, Ruiz E. Copationate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases. Haematologica 2006; 91: 9–11
  • Holowiecki J, Krawczyk-Kulis M, Giebel S, Jagoda K, Stella-Holowiecka B, Piatkowska-Jakubas B, et al. Status of minimal residual disease after induction predicts outcome in both standard and high risk Ph-negative adult acute lymphoblastic leukemia. The Polish Adult Leukemia Group ALL 4-2002 MRD study. Br J Haematol 2008; 142: 227–237
  • Giebel S, Krawczyk-Kulis M, Adamczyk-Cioch M, Jakubas B, Palynyczko G, Lewandowski K, et al. on behalf of the Polish Adult Leukemia Group. Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG). Ann Hematol 2006; 85: 717–722
  • Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005; 23: 4117–4126

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.